[1]
Rukmana, D.S.P.A. et al. 2024. Potential of Tepezza (Teprotumumab) in the Treatment of Active Thyroid Eye Disease (TED) . Jurnal MedScientiae. 3, 2 (Aug. 2024), 120–128. DOI:https://doi.org/10.36452/JMedScientiae.v3i2.3010.